Dividend

In the short-term, Evotec does not expect to report a sustainable positive net income and thus to pay dividends. A future payment of dividends is dependent upon Evotec's financial situation and liquidity requirements, the general market conditions, and statutory, tax and regulatory requirements. Evotec currently intends to retain any profits generated when out-licensing its clinical candidates, and to re-invest to build pipeline value.